Polyvalent immunoglobulins: challenges and perspectives

Affiliations

¹ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
² Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.
³ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.

Review

Isabella Quinti et al. Blood Transfus. 2013 Sep.

. 2013 Sep;11 Suppl 4(Suppl 4):s40-4.

doi: 10.2450/2013.008s.

¹ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
² Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.
³ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.

No abstract available

Figures

1. Council of Europe. Human normal immunoglobulin for intravenous administration Monograph 01/2002:0918 European Pharmacopoeia. 4th ed. Strasbourg: Council of Europe Publishing; 2002. (4.02)
1. Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–9. - PubMed
1. Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11:792–4. - PubMed
1. Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins - understanding properties and mechanisms. Clin Exp Immunol. 2009;158(Suppl 1):2–13. - PMC - PubMed
1. Kaveri SV, Lacroix-Desmazes S, Bayry J. The anti-inflammatory IgG. N Engl J Med. 2008;359:307–9. - PubMed